BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2016 9:54:00 AM | Browse: 841 | Download: 836
Publication Name World Journal of Clinical Cases
Manuscript ID 22114
Country/Territory United States
2015-08-27 10:01
Peer-Review Started
2015-08-27 20:02
To Make the First Decision
2015-10-14 11:21
Return for Revision
2015-10-15 10:21
2015-11-16 01:22
Second Decision
2015-12-07 09:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-12-14 17:49
Articles in Press
2015-12-14 17:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-03 18:50
Publish the Manuscript Online
2016-03-11 09:54
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Case Report
Article Title Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited
Manuscript Source Unsolicited Manuscript
All Author List Jennifer Leong, Derek Lin and Mindie H Nguyen
Funding Agency and Grant Number
Corresponding Author Jennifer Leong, MD, Assistant Professor, Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1104, New York, NY 10029, United States. jennifer.leong@mountsinai.org
Key Words Hepatitis B virus; Hepatitis B surface antigen; Escape mutant; Hepatitis B immunoglobulin; Vaccination
Core Tip Hepatitis B surface antigen escape mutations are being increasingly recognized, along with concern for the risk of transmission to vaccinated individuals. The management of these patients and the natural history of the disease remain controversial due to insufficient data. However, transmission of this mutated virus to vaccinated individuals has been reported in the literature. Herein, we discuss two different clinical scenarios that led to the initiation of early antiviral therapy in order to decrease the risk of transmission to others due to the suspected presence of this mutation.
Publish Date 2016-03-11 09:54
Citation Leong J, Lin D, Nguyen MH. Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited. World J Clin Cases 2016; 4(3): 71-75
URL http://www.wjgnet.com/2307-8960/full/v4/i3/71.htm
DOI http://dx.doi.org/10.12998/wjcc.v4.i3.71
Full Article (PDF) WJCC-4-71.pdf
Full Article (Word) WJCC-4-71.doc
Manuscript File 22114-Review.docx
Answering Reviewers 22114-Answering reviewers.pdf
Audio Core Tip 22114-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 22114-Conflict-of-interest statement.pdf
Copyright License Agreement 22114-Copyright assignment.pdf
Institutional Review Board Approval Form or Document 22114-Institutional review board statement.pdf
Peer-review Report 22114-Peer-review(s).pdf
Scientific Misconduct Check 22114-Scientific misconduct check.pdf
Scientific Editor Work List 22114-Scientific editor work list.pdf